Health
Johnson & Johnson Vaccine Might Save the Company – Live Trading News
Johnson & Johnson Vaccine Might Save the Company Headline News
US health care giant Johnson & Johnson, beset by recent scandals over talcum powder and the opioid crisis, is poised for a reputational lift with its pathbreaking coronavirus vaccine.
J & J, which has vowed to sell the vaccine at cost, won approval Thursday from the European Union for its Covid-19 jab after receiving the green light earlier from regulators in the United States, Canada and South Africa.
The J & J inoculation is the first approved by health authorities to require just one shot, the…
-
Noosa News20 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business21 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News16 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business19 hours agoEverything you need to know about the Coles dividend